SPONTAN® Now Available at TerryWhite Chemmart Pharmacies Nationwide
LTR Pharma is pleased to announce that SPONTAN® is now available through TerryWhite Chemmart’s network of 600+ pharmacies nationwide, marking a pivotal milestone in our patient access strategy. Under our partnership with Symbion, patients with prescriptions from healthcare professionals can now have them filled at participating TerryWhite Chemmart, Pharmacy Choice, and healthSAVE pharmacies across Australia. […]
LTR Pharma Signs Collaborative Development Agreement to Develop a Novel Intranasal Spray for Oesophageal Motility Disorders
LTR Pharma has announced that it has entered into a collaborative development agreement with Strategic Drug Solutions, Inc. (SDS) to co-develop OROFLOW®, a novel intranasal spray for Oesophageal Motility Disorders (OMD). OROFLOW® represents an important expansion of the Company’s nasal spray technology platform, designed to provide rapid symptom relief for patients struggling with swallowing difficulties […]
Conversation Series | Patient Perspectives | Meet Steve Jones
In our latest Conversation Series video, we meet Steve Jones – a prostate cancer survivor whose candid story highlights the profound psychological impact of erectile dysfunction after surgery. Meet Steve Jones – prostate cancer survivor and sexual health advocate When Steve Jones was diagnosed with prostate cancer four years ago, at the age of 56, […]
Conversation Series | Mental Impact of Erectile Dysfunction with Melissa Hadley Barrett
In the second video of our Conversation Series, Sexologist and Nurse Practitioner Melissa Hadley Barrett explores the profound psychological impact erectile dysfunction can have on men’s self-esteem and relationships. Melissa shares a moving case study from her practice where erectile dysfunction led to complete relationship breakdown, with the patient withdrawing from all forms of physical […]
Conversation Series | Understanding Erectile Dysfunction with Melissa Hadley Barrett
In the first video of our Conversation Series with sexologist and nurse practitioner Melissa Hadley Barrett, she discusses the true prevalence of erectile dysfunction across different age groups. Melissa reveals how common ED is – affecting 1 in 10 men under 40, increasing to 4 out of 5 men over 70 – and addresses the […]
LTR Pharma Scientific and Clinical Advisor to present at USANZ 2025 ASM
LTR Pharma has today announced its Chief Scientific and Clinical Advisor, Professor Eric Chung, has been selected to present at USANZ & ANZUNS 2025 ASM to be hosted in Perth from 1-4 March 2025. Co-hosted by the Urological Society of Australian and New Zealand (USANZ) and Australia and New Zealand Urological Nurses Society (ANZUNS), this […]
Conversation Series | Innovations in Treatments for ED with Dr. Tom Silva
In the latest video from our Conversation Series, specialist GP Dr. Tom Silva discusses crucial considerations in clinical practice with regards to ED treatment selection and patient care. Dr. Silva explores how common side effects and delayed action can impact patient confidence, while highlighting how rapid-acting treatments, like SPONTAN, can enhance spontaneity and improve outcomes […]
Medical Forum | The new treatments changing life after prostate cancer
A new Medical Forum article titled ‘The new treatments changing life after prostate cancer’ by journalist Cathy O’Leary has highlighted the need for new Erectile Dysfunction (ED) treatments for men as they navigate the life-changing side effects of prostate cancer treatment. The article features Melissa Hadley Barrett, nurse practitioner, sexologist and founder of the Restorative […]
Quarterly Activities Report and 4C
LTR Pharma has today released its Quarterly Activities Report and Appendix 4C Quarterly Cash Flow report for the quarter ended 31 December 2024. Key highlights from this period include: Breakthrough Final Clinical Data: SPONTAN® achieves 470% faster absorption than oral PDE5 tablets showing it can be effective within 10 minutes Strategic Partnerships: Joint Venture with […]
LTR Pharma Signs National Pharmacy Distribution Agreement with Symbion
LTR Pharma is pleased to announce it has entered into an agreement with Symbion Pty Ltd, a leading pharmaceutical wholesaler in Australia, to establish national distribution capabilities for SPONTAN®. Under the agreement, Symbion will provide warehousing, inventory management and nationwide distribution services for SPONTAN through its extensive network of distribution centres servicing over 3,900 pharmacies […]
Biotech Dispatch | LTR Pharma signs national pharmacy distribution agreement with Symbion
LTR Pharma’s new strategic partnership with Symbion has been featured in Biotech Dispatch. Click to read the article.
Agreement with Australia’s leading Men’s Health Pharmacy for access to SPONTAN®
LTR Pharma is pleased to announce it has entered into an access agreement with Men’s Health Downunder (MHDU) to facilitate access to SPONTAN® through the Therapeutic Goods Administration’s (TGA) Special Access Scheme. MHDU is a specialised men’s health provider operating a multidisciplinary network of healthcare professionals. The partnership has already achieved its first milestone, with […]
The Australian | LTR Pharma inks deal with men’s health provider for ED therapy
LTR Pharma new access agreement with Mens Health Downunder to facilitate supply of SPONTAN has been featured in a Special Report in The Australian newspaper, highlighting the significant unmet need for fast-acting and effect treatments for Erectile Dysfunction. “MHDU founder and executive chairman Brad Butt said the collaboration with LTR Pharma enhances its ability to […]
Early Launch of Online Men’s Health Platform
LTR Pharma’s joint venture partner Restorative Health Clinic has today launched its online men’s health platform ahead of schedule, delivering comprehensive telehealth services to Australian men. The platform combines clinical expertise in men’s health with access to innovative treatments, including SPONTAN®, providing Australian men with convenient access to healthcare professionals and evidence-based treatments. Australian men […]
VIDEO | Break it Down: Quick access to quick ED fix from LTR Pharma
Stockhead TV’s Sarah Hughan presented Break it Down, detailing the online healthcare platform to access erectile dysfunction treatment from LTR Pharma. Take a look:
LTR Pharma completes A$25 million placement to expedite commercialisation of SPONTAN®
LTR Pharma has today announced that it has successfully completed a A$25 million placement to sophisticated and institutional investors to accelerate SPONTAN®’s commercialisation. These funds will accelerate the Company’s progress in the U.S.; increase R&D investment for product portfolio expansion and manufacturing scale-up; and assist with launching an innovative telehealth platform to create a seamless […]
The Australian | LTR Pharma successfully completes $25m cap raise to accelerate novel ED treatment
LTR Pharma’s $25 million placement to support the commercialisation of SPONTAN – its fast-acting nasal spray treatment for erectile dysfunction (ED) – has been reported in The Australia, in a special report titled ‘LTR Pharma successfully completes $25m cap raise to accelerate novel ED treatment.’ Here’s an excerpt: “LTR Pharma chairman Lee Rodne said the […]
Financial Review | Market darling LTR Pharma raises new equity
LTR Pharma’s plans to raise capital via institutional placement were featured in the Financial Review following the Company’s trading halt on Friday. Here’s an excerpt: “Nasal viagra biotech LTR Pharma, whose shares have risen 176 per cent over the past 12 months, was seeking to raise $20 million on Friday via an institutional placement. LTR […]
Dr Boreham’s Crucible | The rise and rise of LTR Pharma
LTR Pharma has been featured in the Stockhead article by respected biotech journalist Tim Boreham titled “The rise and rise of LTR Pharma.” The article highlights the market opportunity for new treatments for Erectile Dysfunction, and LTR Pharma’s strategic path to market in Australia. Here’s an excerpt: “The value of the erectile dysfunction market is […]
Conversation Series | Treatments for ED | Dr Tom Silva
The third video from our Conversation Series with Dr Thomas Silva is now live. Dr Silva is a specialist GP and University of Queensland lecturer with unique expertise in erectile dysfunction treatments, including experience with complex post-prostate cancer cases. In this video, Dr Silva provides a comprehensive overview of current ED medications and their mechanisms […]